August 22, 2025 - 20:35

Shares of restaurant technology provider PAR Technology experienced a notable increase of 6% during the afternoon trading session. This surge came in the wake of a broader market rally, spurred by comments from Federal Reserve Chair Jerome Powell regarding the potential for an interest rate cut at the upcoming September meeting.
Powell's remarks ignited a wave of optimism among investors, as the prospect of lower interest rates typically encourages economic growth by reducing borrowing costs for both companies and consumers. This outlook has historically led to increased investor confidence, which often translates into higher stock prices across various sectors.
As the market reacts to these developments, PAR Technology stands out as a key player in the restaurant technology space, benefiting from the positive sentiment surrounding its stock. Investors will be closely monitoring the situation as they assess the implications of the Federal Reserve's decisions on the economy and their investments in the technology sector.
April 10, 2026 - 03:59
Verneek's Deep Technology Tackles Retail IssuesThe retail sector is turning to sophisticated artificial intelligence to solve persistent operational challenges, with companies like Verneek at the forefront. According to its CEO, Dr. Nasrin...
April 9, 2026 - 12:09
California lawmaker introduces bill to help prevent, de-escalate police chases with new technologyIn a direct response to the dangers of high-speed police pursuits, a California lawmaker has introduced new legislation focused on de-escalation and prevention. The bill arrives amid heightened...
April 8, 2026 - 20:04
Omatic Releases Fourth Annual Nonprofit Technology Ecosystem Trends Report, Uncovers a Sector Drowning in Data—And the Struggle to Trust ItA comprehensive new survey of over 800 nonprofit professionals has uncovered a sector at a critical technological crossroads, grappling with an overwhelming influx of data while simultaneously...
April 8, 2026 - 08:38
Halozyme and Vertex sign deal for Hypercon technologyIn a significant move within the biopharmaceutical industry, Halozyme Therapeutics has entered into an exclusive worldwide partnership and licensing agreement with Vertex Pharmaceuticals. The multi...